Biotechnology Consulting
PK and PD as predictors of clinical effect. 2 PKPD workshop at AGAH/Club Phase I drug action – the interaction of the drug molecule at the binding site.
SANGUINATE TM Toxicology and Safety Determination
06.05.20110 Dr. Agnieszka Turowska Warsaw, 2015 Spin-off in practice German experience from Polish perspective.
PK and PD as predictors of clinical effect
Food and Drug Administration Center for Biologics Evaluation and Research The Office of Cellular, Tissue, and Gene Therapies Web Seminar Series presents:
Stentorian August 2013
